Work-up of a Bleeding Child

Textbook of Hemophilia: Second Edition

Volumn , Issue , 2010, Pages 118-126

  Carcao, Manuel D ^a   Blanchette, Victor S ^a,b  

^a HOSPITAL FOR SICK CHILDREN   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Bleeding child's work up; Bleeding type, of great value in making diagnosis; Child referred, of suspected bleeding disorder detailed medical and bleeding history; Eczema in patients with Wiskott Aldrich syndrome; Family history, clues to potential inheritance of underlying bleeding disorder; Hemostatic system, regulated balance of procoagulant, anticoagulant and fibrinolytic forces; Key mediators in platelet aggregation, including platelet GPIIb IIIa receptors; Little racial or ethnic predisposition to bleeding disorders; Oculocutaneous albinism in Hermansky Pudlak or Chediak Higashi syndrome patients; Von Willebrand factor (VWF) role in linking platelets through glycoprotein GPIb

Indexed keywords

EID: 84863330934     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781444318555.ch18     Document Type: Chapter

References (59)

1. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70: 165-72.
2. Andrew M, Paes B, Milner R, et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72: 1651-7.
3. Andrew M, Vegh P, Johnston M, et al. Maturation of the hemostatic system during childhood. Blood 1992; 80: 1998-2005.
4. Furie B, Furie BC. Mechanisms of thrombus formation. N Engl J Med 2008; 359: 938-49.
5. Zipursky A, deSa D, Hsu E, et al. Clinical and laboratory diagnosis of hemostatic disorders in newborn infants. Am J Pediatr Hematol Oncol 1979; 1: 217-26.
6. Levi M, Ten Cate H. Disseminated intravascular coagulation. N Engl J Med 1999; 341: 586-92.
7. Lisman T, Leebeek FW, de Groot PG. Haemostatic abnormalities in patients with liver disease. J Hepatol 2002; 37: 280-7.
8. Monagle P, Andrew M. Acquired disorders of hemostasis. In: Nathan DG, Orkin SH, Ginsburg D, Look AT (eds). Nathan and Oski ' s Hematology of Infancy and Childhood, Vol. 2, 6th edn. Philadelphia: WB Saunders; 2003: 1631-67.
9. Acharya SS, DiMichele DM. Rare inherited disorders of fibrinogen. Haemophilia 2008; 14: 1151-8.
10. Dreyfus M, Kaplan C, Verdy E, et al. Frequency of immune thrombocytopenia in newborns: A prospective study. Immune Thrombocytopenia Working Group. Blood 1997; 89: 4402-6.
11. Dean JA, Blanchette VS, Carcao MD, et al. von Willebrand disease in a pediatric-based population - Comparison of type 1 diagnostic criteria and use of the PFA-100 and a von Willebrand factor/ collagen-binding assay. Thromb Haemost 2000; 84: 401-9.
12. Rodeghiero F, Castaman G, Tosetto A, et al. The discriminant power of bleeding history for the diagnosis of type 1 von Willebrand disease: An international, multicenter study. J Thromb Haemost 2005; 3: 2619-26.
13. Tosetto A, Castaman G, Rodeghiero F. Bleeding scores in inherited bleeding disorders: Clinical or research tools? Haemophilia 2008; 14: 415-22.
14. Rodeghiero F, Kadir RA, Tosetto A, James PD. Relevance of quantitative assessment of bleeding in haemorrhagic disorders. Haemophilia 2008; 14 ( Suppl. 3 ): 68-75.
15. Katsanis E, Luke KH, Hsu E, Li M, Lillicrap D. Prevalence and significance of mild bleeding disorders in children with recurrent epistaxis. J Pediatr 1988; 113: 73-6.
16. Higham JM, O ' Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990; 97: 734-9.
17. Buchanan GR, Adix L. Grading of hemorrhage in children with idiopathic thrombocytopenic purpura. J Pediatr 2002; 141: 683-8.
18. Nishino M, Girma JP, Rothschild C, et al. New variant of von Willebrand disease with defective binding to factor VIII. Blood 1989; 74: 1591-9.
19. Mazurier C, Meyer D. Factor VIII binding assay of von Willebrand factor and the diagnosis of type 2N von Willebrand disease - Results of an international survey. On behalf of the Subcommittee on von Willebrand Factor of the Scientific and Standardization Committee of the ISTH. Thromb Haemost 1996; 76: 270-4.
20. Schneppenheim R, Budde U, Krey S, et al. Results of a screening for von Willebrand disease type 2N in patients with suspected haemophilia A or von Willebrand disease type 1. Thromb Haemost 1996; 76: 598-602.
21. Peretz H, Mulai A, Usher S, et al. The two common mutations causing factor XI deficiency in Jews stem from distinct founders: One of ancient Middle Eastern origin and another of more recent European origin. Blood 1997; 90: 2654-9.
22. Kanaji T, Okamura T, Osaki K, et al. A common genetic polymorphism (46 C to T substitution) in the 5 '-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 1998; 91: 2010-14.
23. Gordon EM, Donaldson VH, Saito H, Su E, Ratnoff OD. Reduced titers of Hageman factor (Factor XII) in Orientals. Ann Intern Med 2001; 95: 697.
24. Seri M, Pecci A, Di Bari F, et al. MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness. Medicine (Baltimore) 2003; 82: 203-15.
25. Harrison P. The role of PFA-100 testing in the investigation and management of haemostatic defects in children and adults. Br J Haematol 2005; 130: 3-10.
26. Hanseler E, Fehr J, Keller H. Estimation of the lower limits of manual and automated platelet counting. Am J Clin Pathol 1996; 105: 782-7.
27. Bizzaro N. EDTA-dependent pseudothrombocytopenia: A clinical and epidemiological study of 112 cases, with 10-year follow-up. Am J Hematol 1995; 50: 103-9.
28. Giles C. The platelet count and mean platelet volume. Br J Haematol 1981; 48: 31-7.
29. Gohda F, Uchiumi H, Handa H, et al. Identification of inherited macrothrombocytopenias based on mean platelet volume among patients diagnosed with idiopathic thrombocytopenia. Thromb Res 2007; 119: 741-6.
30. Racchi O, Rapezzi D. Megathrombocytes and spurious thrombocytopenia. Eur J Haematol 2001; 66: 140-1.
31. Balduini CL. Giant platelet syndromes and the MYH9 mutations. Lab Hematol 2004; 10: 187-8.
32. Andrew M, Castle V, Mitchell L, Paes B. Modified bleeding time in the infant. Am J Hematol 1989; 30: 190-1.
33. Rodgers RP, Levin J. A critical reappraisal of the bleeding time. Semin Thromb Haemost 1990; 16: 1-20.
34. Jilma B. Platelet function analyzer (PFA-100): A tool to quantify congenital or acquired platelet dysfunction. J Lab Clin Med 2001; 138: 152-63.
35. Carcao MD, Blanchette VS, Dean JA, et al. The Platelet Function Analyzer (PFA-100): A novel in-vitro system for evaluation of primary hemostasis in children. Br J Haematol 1998; 101: 70-3.
36. Favaloro EJ. Clinical application of the PFA-100. Curr Opin Hematol 2002; 9: 407-15.
37. Quiroga T, Goycoolea M, Mu ñ oz B, et al. Template bleeding time and PFA-100 have low sensitivity to screen patients with hereditary mucocutaneous hemorrhages: Comparative study in 148 patients. J Thromb Haemost 2004; 2: 892-8.
38. Hayward CP, Harrison P, Cattaneo M, et al. The Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Platelet function analyzer (PFA)-100 closure time in the evaluation of platelet disorders and platelet function. J Thromb Haemost 2006; 4: 312-19.
39. Shah MD, O ' Riordan MA, Alexander SW. Evaluation of prolonged aPTT values in the pediatric population. Clin Pediatr 2006; 45: 347-53.
40. Humphries JE, Acker MN, Pinkston JE, Ruddy S. Transient lupus anticoagulant associated with prothrombin deficiency: Unusual cause of bleeding in a 5-year-old girl. Am J Pediatr Hematol Oncol 1994; 16: 372-6.
41. Endler G, Marsik C, Jilma B, et al. Evidence of a U-shaped association between factor XII activity and overall survival. J Thromb Haemost 2007; 5: 1143-8.
42. Cumming AM, Jones GR, Wensley RT, Cundall RB. In vitro neutralization of heparin in plasma prior to the activated partial thromboplastin time test: An assessment of four heparin antagonists and two anion exchange resins. Thromb Res 1986; 41: 43-56.
43. Funk C, Gmur J, Herold R, Straub PW. Reptilase-R - A new reagent in blood coagulation. Br J Haematol 1971; 21: 43-52.
44. Thompson AR, Counts RB. Removal of heparin and protamine from plasma. J Lab Clin Med 1976; 88: 922-9.
45. Sadler JE, Budde U, Eikenboom JC, et al.; Working Party on von Willebrand Disease Classification. Update on the pathophysiology and classification of von Willebrand disease: A report of the Subcommittee on von Willebrand Factor. J Thromb Haemost 2006; 4: 2103-14.
46. Lillicrap D, Nair SC, Srivastava A, et al. Laboratory issues in bleeding disorders. Haemophilia 2006; 12 ( Suppl. 3 ): 68-75.
47. Gill JC, Endres-Brooks J, Bauer PJ, et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
48. Miller JL, Castella A. Platelet-type von Willebrand ' s disease: Characterization of a new bleeding disorder. Blood 1982; 60: 790-4.
49. Weiss HJ, Meyer D, Rabinowitz R, et al. Pseudo-von Willebrand ' s disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers. N Engl J Med 1982; 306: 326-33.
50. Favaloro EJ. Laboratory assessment as a critical component of the appropriate diagnosis and sub-classification of von Willebrand ' s disease. Blood Rev 1999; 13: 185-204.
51. Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost 2003; 1: 1628-36.
52. Nurden P, Nurden A. Congenital disorders associated with platelet dysfunctions. Thromb Haemost 2008; 99: 253-63.
53. Cines DB, Blanchette VS. Immune thrombocytopenic purpura. N Engl J Med 2002; 346: 995-1008.
54. Hayward CP, Rao AK, Cattaneo M. Congenital platelet disorders: Overview of their mechanisms, diagnostic evaluation and treatment. Haemophilia 2006; 12 ( Suppl. 3 ): 128-36.
55. Hayward CP. Diagnostic approach to platelet function disorders. Transfus Apher Sci 2008; 38: 65-76.
56. Witkop CJ, Krumwiede M, Sedano H, White JG. Reliability of absent platelet dense bodies as a diagnostic criterion for Hermansky-Pudlak syndrome. Am J Hematol 1987; 26: 305-11.
57. Israels SJ, McNicol A, Robertson C, Gerrard JM. Platelet storage pool deficiency: Diagnosis in patients with prolonged bleeding times and normal platelet aggregation. Br J Haematol 1990; 75: 118-21.
58. Kunishima S, Matsushita T, Kojima T, et al. Immunofl uorescence analysis of neutrophil nonmuscle myosin heavy chain-A in MYH9 disorders: Association of subcellular localization with MYH9 mutations. Lab Invest 2003; 83: 115-22.
59. Balduini CL, Iolascon A, Savoia A. Inherited thrombocytopenias: From genes to therapy. Haematologica 2002; 87: 860-80.